SCK CEN is the Belgian Nuclear Research Centre that engages in research and development in the field of nuclear technology, focusing on various nuclear applications and societal challenges.

SCK CEN

PanTera aims to secure the large-scale production of actinium-225 (Ac-225), targeting its use in radiopharmaceuticals for personalized cancer treatment. The company focuses on improving the accessibility of innovative cancer therapies based on Ac-225.

PanTera

SCK CEN | 15,307 followers on LinkedIn. Exploring a better tomorrow | Do not underestimate the power of atoms: nuclear applications can make a great difference for society both now and in the future. This is why as one of the biggest research centres in Belgium we continue to perform groundbreaking research. SCK CEN is a global leader in the field of nuclear research, services and education.

Increasing Customer and Business Value through operational excellence and strategic programs

Bert Cuypers

Secretary General European Corporate Security Association - ECSA

ir. Yvan De Mesmaeker (M.Sc.Eng.)

Tom Dams

Director of the Sustainable Waste & Decommissioning Institute, SCK CEN

Didier LEONARD

🌐🔬 Happy International STEM Day! 🚀✨ Today, we celebrate the power of Science, Technology, Engineering, and Mathematics. As we reflect on the incredible impact of STEM, let’s shine a spotlight on a field where innovation meets public safety: nuclear and radiological safety. Ensuring the safety of nuclear installations is more crucial than ever, with continuous advancements in technology, risk management, and environmental protection. From safeguarding communities to protecting our environment, these fields are essential for a secure and sustainable future. 🌱🔒⚛️ Young minds eager to make a difference will find exciting opportunities here. Careers in nuclear and radiological safety are about developing cutting-edge solutions, ensuring long-term safety standards, and playing a vital role in keeping our world safe. It’s a chance to combine engineering brilliance with a deep commitment to societal well-being. 🌍✨ The future of safety innovation awaits—will you be the one to lead it? 🚀💡 #InternationalSTEMDay #NuclearSafety #STEMCareers #RadiologicalProtection #InnovationForSafety #FutureOfSTEM #ShapeTheFuture

FANC - Federal Agency for Nuclear Control

📣 Exciting career opportunities at SCK CEN, the Belgian Nuclear Research Centre! ☢️ Are you ready to join the forefront of nuclear innovation and make a positive impact on our future? We are thrilled to announce 2 OPEN VACANCIES within our expert teams! 👨🔬 Lab technicien: contribute to the development and design of experimental installations. 👷 Construction manager: develop a construction and commissioning strategy for the MINERVA project. 👀 Interested? Visit our website to learn more about each position and apply. 🔗 https://lnkd.in/e-ScS2SC #SCKCEN #nuclear #career #opportunities #Innovation #sustainability

#International (EN ⤵) ✔Just one day after the #EURAD -2 kick-off, we looked back at the Belgian accomplishments of EURAD-1 last Friday, with the 26th Exchange Meeting on the management of radioactive waste. This event was organized, as every year, by the #EURIDICE team in collaboration with partners #ONDRAFNIRAS and SCK CEN , and was once again held at #Tabloo . 📢 Indeed, we focused on the Belgian contributions to EURAD, the European Joint programme on radioactive waste management which is co-funded by the European Commission. With contributions from numerous experts at #SCKCEN , #ONDRAFNIRAS , FANC - Federal Agency for Nuclear Control , and BelV , we presented a rich program for technical experts, stakeholders, and interested parties. The impressive expertise in radioactive waste management in our country was evident from the many talks covering all work packages of EURAD-1. The connection to the Belgian program was always present, highlighting the importance of participating in such international projects for long-term waste management. ✍️ That international collaboration enhances our ability to critically assess knowledge and scientific advancements, reinforcing the safety of geological disposal. While we embrace these opportunities, it's vital to remain focused on our national priorities to ensure a balanced approach to progress. Together, we can navigate the complexities of geological disposal while fostering innovation and safety. 💪 Great work from everyone involved, still a lot of work to come! #Belgianprogramme #déchetsradioactifs #radioactiefafval #radioactivewastemanagement #researchanddevelopment

ONDRAF/NIRAS Belgian Agency for Radioactive Waste and Enriched Fissile Materials

🏁 Belgian experts are ready to continue tackling the challenges of radioactive waste management at the European level 🏁 🔎 EURAD, the European Joint programme on radioactive waste management funded by #EURATOM , organized the kick-off meeting of the second leg of the project in Ghent this week. In EURAD-2, the focus is put on both geological disposal and the further optimization of surface disposal facilities, combining the goals of PREDIS (EU-project on Pre-disposal Management of Radioactive Waste) and EURAD-1 (on research topics related to geological disposal). EURAD-2 has a more strategic orientation, with 6 of the 18 work packages being strategic studies running for 2 years. The R&D studies will again run for 5 years. EURAD-2 is aiming to screen the status specific topics and the needs from different countries to either conclude elements of the research or prepare topics for more in-depth study. 🤝 Belgium, with more than 40 years of experience in deep geological disposal RD&D, remains a powerful voice at the European level. Belgian involvement can be found in 17 of the 18 work packages, which is truly impressive. We expect to learn a great deal from this project for our Belgian programme but also to contribute to the work thanks to our expertise and decades-long experience. #nuclearlifecycle #waste #disposal #research #Belgium

Reusing NORM waste to produce paper, cement and batteries - we are working on it! ☢️♻️ 🤝 Together with the FIC Fighters team, we aim to transform phosphogypsum waste into valuable materials for reuse in consumer products. SCK CEN will take on the radiological characterization of both the production site and the final recovered end-products. 🔬 Moreover, we will also assist with scientific studies and communication to inform the public about the benefits and safety of phosphogypsum recycling. 💬 Talk about multidisciplinarity and sustainability! 💪 Read more on our website: https://lnkd.in/evcv5Bnk #nuclearlifecycle #recycling #NORM #FICFighters #innovation #teamwork

Exciting results about terbium-161 and its potential in cancer treatment were shared by Kaat Spoormans during her presentation at #EANM 2024, recognized as one of the must-see sessions of the event! 💡 Terbium-161 has a unique property: when it decays, it emits both internal conversion and low-energy Auger electrons next to a beta particle. ☢️ Like alpha particles, these electrons travel very short distances, allowing a higher dose to accumulate locally near cancer cells with each injection. In theory, this results in a stronger therapeutic effect while sparing healthy tissue. 💬 "Our research shows that the internal conversion electrons emitted by Terbium-161 indeed deliver a significantly higher absorbed dose compared to Lutetium-177. However, to truly enhance the biological effectiveness of 161Tb, the Auger electrons must be precisely targeted at radiosensitive areas of the cell – such as the cell nucleus, the mitochondria or the cell membrane. While 161Tb-DOTATATE internalises into the cell cytoplasm, 161Tb-DOTA-LM3 binds to the cell membrane, allowing for a more focused and enhanced therapeutic effect," Kaat Spoormans explained. These insights are a significant step forward in precision cancer treatment. 🎯 Take away – European Association of Nuclear Medicine (EANM) . Missed the session at EANM '24? You can find her paper here for all the details! 📄 https://lnkd.in/eCCHi-SC

📅 Only 1 day left to connect with us at the European Association of Nuclear Medicine (EANM) conference - don't miss out! Be sure to stop by and engage with our team. We're live at booth H32, where our experts are ready to share their insights on radioligand therapy. 💡 Swing by for practical tips and discover how our preclinical research can be your ideal partner in advancing cancer treatment. Learn more about our comprehensive services, from cutting-edge fundamental research to radiochemical purification. Together, let's achieve your strategic goals and make a significant impact on the future of healthcare! 💪 #EANM2024 #cancerresearch #healthcare #nuclearmedicine #Hamburg

How is SCK CEN a pioneer in radioligand therapies? 🔬 By leveraging our multidisciplinary expertise to fuel cancer research; 🔗 By enabling a supply chain for radioisotopes; 🏥 And by reaching out to clinical centers to treat patients. ☢️ Our vision is clear: collaborate to bring radioligand therapy to the next level and impact more lives around the globe. 🎥 Check out our video to learn how we are pushing the boundaries of cancer therapy. 👁️🗨️ Do you share this vision, this mission? Let's talk! https://lnkd.in/exqcYrmc

💉 Can Belgium become the hub for radioligand therapies against cancer? And what are we doing with SCK CEN to get our country into that pole position? Koen Hasaers , our Director of Nuclear Medical Applications, has an idea. 💡 Thanks to Novartis for the question and the video! What are your ambitions in the fight against cancer? 🎤 Tell us, for example during European Association of Nuclear Medicine (EANM) . You will find us at booth H32!

Kudos to SpectronRx ! 💪 Honored to host their first European readiolabeling facility at our site. Proud to collaborate and contribute to advancing nuclear medicine together!

Metric
Company Name	SCK CEN	PanTera
Symbol
MSH ID	BE:SCKCEN	COM:PANTERA-LIFE
Market	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services
Industry	Nuclear Research	Biotechnology
Country	BE	BE
Stage
Employee Count
Website	sckcen.be	pantera-life.com
LinkedIn	sckcen
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		3.34K
Web Traffic Growth		0.82
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SCKC

BE:SCKCEN

SCK CEN

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue